Akero Therapeutics Inc. (AKRO)
NASDAQ: AKRO
· Real-Time Price · USD
49.42
-0.67 (-1.34%)
At close: Aug 15, 2025, 3:59 PM
48.69
-1.48%
After-hours: Aug 15, 2025, 07:10 PM EDT
Akero Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 220.45M | 185.92M | 340.24M | 316.06M | 310.36M | 623.85M | 234.21M | 269.55M | 444.16M | 257.88M | 249.77M | 374M | 177.73M | 150.49M | 150.48M | 164.94M | 157.54M | 187.96M |
Short-Term Investments | 521.87M | 500.37M | 402.84M | 401.18M | 449.84M | 279.81M | 315.8M | 285.19M | 195.29M | 85.34M | 101.68M | n/a | 3M | 14.89M | 37.77M | 50.15M | 72.49M | 62.02M |
Long-Term Investments | 343.93M | 442M | 54.75M | 69.82M | 88.13M | n/a | 19.28M | 58.26M | 19.45M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 108K | 108K | 108K | 108K | 468K | 417K | 114K | 115K | 115K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 22.29M | 26.86M | 27.3M | 29.64M | 15.82M | 7.62M | 9.95M | 21.25M | 3.76M | 4.27M | 3.72M | 3.94M | 3.42M | 2.56M | 5.32M | 6.73M | 6.19M | 5.79M |
Total Current Assets | 764.6M | 713.15M | 770.38M | 746.89M | 776.01M | 911.28M | 559.96M | 575.98M | 643.2M | 347.49M | 355.17M | 377.95M | 184.15M | 167.93M | 193.58M | 221.81M | 236.22M | 255.78M |
Property-Plant & Equipment | 621K | 689K | 755K | 835K | 900K | 963K | 1.03M | 1.09M | 1.15M | 1.22M | 1.29M | 1.35M | 1.42M | 1.49M | 1.55M | 1.61M | 1.67M | 1.73M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 344.55M | 442.69M | 55.51M | 70.66M | 89.03M | 963K | 20.31M | 59.35M | 20.6M | 1.33M | 1.4M | 1.46M | 1.53M | 1.95M | 1.97M | 1.73M | 1.79M | 1.85M |
Total Assets | 1.11B | 1.16B | 825.89M | 817.55M | 865.04M | 912.24M | 580.27M | 635.33M | 663.81M | 348.82M | 356.57M | 379.41M | 185.68M | 169.89M | 195.55M | 223.53M | 238.01M | 257.62M |
Account Payables | 13.25M | 10.83M | 9.03M | 25.22M | 14.57M | 13.78M | 7.04M | 11.45M | 10.12M | 7.08M | 7.97M | 6.01M | 6.88M | 4.45M | 6.71M | 6.78M | 2.31M | 4.61M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -493K | n/a | n/a | n/a | -255K | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 13.5M | 6.66M | 291K | 631K | 629K | 640K | 260K | 2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 28.78M | 2.77M | 1.22M | 4.09M | 12.58M | 13.34M | 1.04M | n/a | 8.62M | 7.45M | 9.99M | 16.36M | 17.66M | 15.98M | 17.66M | 14.34M | 1.59M | 965K |
Total Current Liabilities | 60.4M | 42.44M | 39.75M | 43.29M | 31.17M | 30.26M | 19.13M | 28.45M | 21.6M | 16.68M | 19.08M | 25.24M | 26.7M | 22.1M | 25.13M | 23.54M | 16.46M | 10.14M |
Long-Term Debt | 22.16M | 28.81M | 35.3M | 35.12M | 34.96M | 34.8M | 24.96M | 22.77M | 24.73M | 24.62M | 9.54M | 9.45M | 9.37M | 1.25M | 1.31M | 1.36M | 1.42M | 1.47M |
Other Long-Term Liabilities | 400K | 296K | 194K | 203K | 164K | 178K | 54K | 93K | 85K | 162K | 305K | 70K | 41K | -1.25M | -1.31M | -1.36M | -1.42M | -1.47M |
Total Long-Term Liabilities | 22.93M | 29.56M | 36.02M | 35.93M | 35.8M | 35.73M | 25.84M | 23.75M | 25.77M | 25.8M | 10.93M | 10.66M | 10.61M | 1.25M | 1.31M | 1.36M | 1.42M | 1.47M |
Total Liabilities | 83.33M | 72M | 75.77M | 79.22M | 66.98M | 65.99M | 44.97M | 52.2M | 47.37M | 42.47M | 30.01M | 35.9M | 37.3M | 23.35M | 26.44M | 24.91M | 17.88M | 11.6M |
Total Debt | 37.19M | 36.57M | 36.12M | 36.36M | 36.27M | 36.19M | 26.3M | 26.24M | 26.18M | 26.04M | 10.95M | 10.89M | 10.82M | 1.47M | 1.52M | 1.56M | 1.64M | 1.8M |
Common Stock | 8K | 8K | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 4K | 4K |
Retained Earnings | -967.39M | -896.88M | -826.16M | -756.13M | -683.43M | -627.44M | -574.1M | -518.91M | -479.25M | -448.17M | -422.34M | -399.28M | -363.74M | -336.33M | -310.3M | -277.88M | -253.55M | -224.62M |
Comprehensive Income | 988K | 1.08M | 948K | 2.1M | -261K | -79K | 270K | -506K | -251K | 21K | 37K | 0.00 | -3K | -30K | -27K | -17K | -9K | -2K |
Shareholders Equity | 1.03B | 1.08B | 750.11M | 738.33M | 798.07M | 846.25M | 535.31M | 583.13M | 616.44M | 306.35M | 326.56M | 343.51M | 148.37M | 146.53M | 169.11M | 198.63M | 220.13M | 246.02M |
Total Investments | 865.8M | 942.37M | 457.59M | 471.01M | 537.97M | 279.81M | 335.09M | 343.45M | 214.74M | 85.34M | 101.68M | n/a | 3M | 14.89M | 37.77M | 50.15M | 72.49M | 62.02M |